DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/t4zsbp/live_cell_imaging) has announced the addition of the "Live Cell Imaging Market by Product, Technology & by Application - Analysis & Global Forecast to 2019" report to their offering.
The global live cell imaging market is expected to reach $5.45 Billion by 2019 from $3.57 Billion in 2014, growing at a CAGR of 8.8% from 2014 to 2019.
The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the fastest rate during the forecast period.
Live cell imaging involves the study of living cells though the use of images acquired from microscopes and high-content screening systems. It has become a popular analytical tool for elucidation of biological mechanisms and for the study of the dynamic functions of a cell.
The global market is segmented on the basis of products, technologies, applications, and regions. Based on products, the market is categorized into equipment, consumables, and software. In 2014, the equipment segment accounted for the largest share of the market. The equipment segment is further segmented into microscopes, standalone systems, cell analyzers, and image-capturing devices. In 2014, the microscopy segment accounted for the largest share of the live cell imaging equipment market. The consumables segment is further segmented into assay kits, reagents, media, and others. In 2014, the assay kits segment accounted for the largest share of the consumables market.
Based on technologies, the live cell imaging market is segmented into fluorescence resonance energy transfer (FRET), fluorescence in situ hybridization (FISH), high-content analysis (HCA), fluorescence recovery after photobleaching (FRAP), ratiometric imaging, total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE), and other technologies. The fluorescence resonance energy transfer (FRET) segment accounted for the largest share of the market.
Based on applications, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. In 2014, the cell biology segment accounted for the largest share of the market.
The key factors that are expected to spur the growth of this market are increase in demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies. Moreover, emerging Asian markets, adoption of high-content screening for primary screening, and increasing application of live cell imaging techniques in personalized medicine are likely to create huge opportunities for the market. However, factors such as high cost of high-content screening systems and shortage of knowledgeable and skilled professionals are likely to pose as a deterrent for the growth of this market.
Some of the major players in the global market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
For more information visit http://www.researchandmarkets.com/research/t4zsbp/live_cell_imaging
